Patient-Centric Mobile Apps: Key Opportunities and Challenges for Pharma

Dozens of new health apps for smartphones and tablets are produced monthly. Hundreds of thousands already exist. What does it take for a patient app to stand out in this crowded space? What are the essential ingredients that differentiate an app for patients…and for pharma?

A well-designed app has the potential to increase the quality and efficiency of healthcare, to empower patients to manage their health better, and to deliver an experience patients will remember. Getting apps right is critical if Pharma is to successfully transform itself into a truly patient-centered business.

Patient-centric Mobile Apps: Key Opportunities and Challenges for Pharma gives you the information you need to understand what patients, healthcare providers and other stakeholders want in a healthcare app — and how a successful one promotes health outcomes and positive customer experiences.

Answers to Key Questions

How can pharma leverage apps to improve relationships with patients?
What does it take for healthcare providers to become advocates of your app?
What are the essential elements of a successful patient-centric healthcare app?
What types of apps are most widely recommended to patients by healthcare providers, and how do these apps augment patient care?

Key Issues Explored

Capturing and leveraging the real-world data that apps generate
Building and managing the 24/7 relationship with customers and patients through apps
Critical success factors for patient apps
How to measure and demonstrate ROI of patient apps
The future of patient apps and pharma’s evolving role

Top Takeaways

Your next partner could be a tech giant
Customer experience is now part of your job description, and you need to ace it
Healthcare apps are effectively medical devices and could be at risk for increased regulatory scrutiny
Longevity of the patient relationship will drive future app development
Learn what the customer needs before designing an app
Pharma must keep challenging itself to align communications and engagement strategies with the multichannel options available

Request Sample Pages

Content Highlights

The rise of and reasons for health telematics

Paternalistic to patient-centric medicine
Mobile health is the new normal
Patient-centricity is facilitated through smart patients using smartphones

How patients use apps

ROI is determined differently between patients and pharma
Components, functionality and use: the essential elements of apps
Co-creating apps with patients: entrepreneurs and collaboration with organisations
CASE STUDY: ManAge

The value of apps for general healthcare providers

The consumer patient: health apps
App use by governmental organisations – public health, epidemiology and resource economies
App use by patient organisations

How the pharmaceutical industry views apps

Strategy, sales tool or service?
An early rush to create apps has left mixed opinions about industry’s intentions
Longevity of the patient relationship will drive future app development

The use and value of apps by HCPs

Digital native or traditional physician: app confidence and use
Augmenting patient care with apps
CASE STUDY: SERMO – A crowdsourcing app to expedite clinical diagnosis

The future for app development and use

Generating real-world data for real-world solutions
Regulation: roles of regulatory and medical organisations
Competitive collaboration within pharma

Expert Contributors

Helena Binder, Communications Director, European Patient Panel
Michael Bodenstab, Vice President, Healthcare Solutions, Physicians Interactive
Neil Chandler, Vice President Commercial Excellence, Daiichi Sankyo
Jeremy Dalnes, Worldwide Director, Digital Strategy and Platforms, J&J
Flourent Edouard, Vice President, Commercial Excellence, AstraZeneca
Leigh Hope, Senior Product Manager, Novo Nordisk
Richard Evans, Founding Director, NexGen Healthcare
Rod Fernandez-Baca, Business Unit Director, Gilead
David Gillen, Head Patient Safety, Celgene
Helen Harrison, Digital Director, EMEA, Lilly
Dr Roger Henderson, General Practitioner, UK
Wills Hughes-Wilson, Chief Patient Access Officer, Sobi
Matt Jamieson-Evans, HealthUnlocked
Christine Jordens, Business Support Team Leader, Boehringer Ingelheim
Bernard Levy, Operations Director, Oncology, Roche
Christian Lindknud, Business Manager, Fujirebio
Dr Graeme Moyle, Director of Clinical Trials, Chelsea & Westminster Hospital
Dr Ali Parsa, CEO, Babylon Health
Rebecca Reeve, Head of KOL Relationships, UK & Ireland, Sanofi
Benjamin Tilly, Multichannel Marketing Lead, UK & Ireland, GSK

About FirstWord

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.

FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.

Dossier reports present unbiased and concise analysis based on interviews with leading industry experts on important trends and challenging issues affecting the pharma industry today.

Questions? Please contact us at info@fwreports.com.

Contact Us